Dystrobrevin: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 10:03, 17 March 2025
Dystrobrevin is a protein that in humans is encoded by the DTNA gene. Dystrobrevin is a component of the Dystrophin-associated protein complex (DAPC), which plays a crucial role in muscle function. Mutations in this gene can lead to different forms of muscular dystrophy.
Function[edit]
Dystrobrevin is a cytoplasmic component of the DAPC. It binds to syntrophin, a peripheral membrane protein, which in turn binds to dystrophin, a protein that connects the cytoskeleton to the extracellular matrix. This complex is thought to protect muscle fibers from injury.
Clinical significance[edit]
Mutations in the DTNA gene can lead to left ventricular noncompaction (LVNC), a rare form of cardiomyopathy. This condition is characterized by a thick, spongy layer in the left ventricle of the heart, which can lead to heart failure, arrhythmia, and thromboembolism.
See also[edit]
- Dystrophin
- Dystrophin-associated protein complex
- Syntrophin
- Muscular dystrophy
- Left ventricular noncompaction
References[edit]
<references />


